We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.14%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.97B
AUM Growth
-$688M
(-10%)
Cap. Flow
-$778M
Cap. Flow
% of AUM
-13.04%
Top 10 Holdings %
Top 10 Hldgs %
12.48%
Holding
1,150
New
217
Increased
235
Reduced
398
Closed
276
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$51.8M |
| 2 |
Visa
V
|
+$46.4M |
| 3 |
Comcast
CMCSA
|
+$45.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$36.3M |
| 5 |
Norfolk Southern
NSC
|
+$30.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$52.2M |
| 2 |
Starbucks
SBUX
|
+$51M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$41.7M |
| 4 |
Eli Lilly
LLY
|
+$40.3M |
| 5 |
Booking.com
BKNG
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.23% |
| 2 | Industrials | 13.43% |
| 3 | Financials | 12.16% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Healthcare | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
NACCO Industries
NC
$353M
| $312K | 0.01% |
25,212
-787
| -3% | -$10.3K |
|
752
Alpha and Omega Semiconductor
AOSL
$923M
| $311K | 0.01% |
42,254
-4,400
| -9% | -$32.6K |
|
|
SYUT
753
DELISTED
Synutra International, Inc.
SYUT
| $310K | 0.01% |
46,373
+24,273
| +110% | +$186K |
|
754
PepsiCo
PEP
$186B
| $305K | 0.01% |
3,650
-1,670
| -31% | -$136K |
|
755
Visteon
VC
$2.77B
| $305K | 0.01% |
3,450
+830
| +32% | +$69.1K |
|
756
Ross Stores
ROST
$76.6B
| $303K | 0.01% |
8,460
-264,950
| -97% | -$9.4M |
|
|
REXX
757
DELISTED
Rex Energy Corporation
REXX
| $298K | 0.01% |
+1,595
| New | +$291K |
|
758
KRONOS Worldwide
KRO
$761M
| $295K | ﹤0.01% |
+17,705
| New | +$285K |
|
|
HALL
759
DELISTED
Hallmark Financial Services, Inc.
HALL
| $294K | ﹤0.01% |
3,537
-320
| -8% | -$28K |
|
760
ANI Pharmaceuticals
ANIP
$1.77B
| $293K | ﹤0.01% |
+9,339
| New | +$248K |
|
761
Universal Insurance Holdings
UVE
$1.16B
| $290K | ﹤0.01% |
22,800
| – | – |
|
|
HILL
762
DELISTED
DOT HILL SYSTEMS CORP
HILL
| $289K | ﹤0.01% |
74,559
-33,900
| -31% | -$153K |
|
763
Mercury Insurance
MCY
$5.94B
| $287K | ﹤0.01% |
+6,369
| New | +$291K |
|
764
Patrick Industries
PATK
$2.8B
| $287K | ﹤0.01% |
+21,870
| New | +$243K |
|
|
COBZ
765
DELISTED
CoBiz Financial,Inc
COBZ
| $287K | ﹤0.01% |
24,952
-8,700
| -26% | -$98.4K |
|
|
ARC
766
DELISTED
ARC Document Solutions, Inc.
ARC
| $286K | ﹤0.01% |
+38,400
| New | +$288K |
|
|
MEA
767
DELISTED
METALICO INC
MEA
| $284K | ﹤0.01% |
174,093
+42,300
| +32% | +$85.7K |
|
|
EDMC
768
DELISTED
EDUCATION MGMT CORP NEW COM STK (PA)
EDMC
| $283K | ﹤0.01% |
+58,049
| New | +$404K |
|
|
EGIO
769
DELISTED
Edgio, Inc. Common Stock
EGIO
| $282K | ﹤0.01% |
3,232
-2,198
| -40% | -$186K |
|
770
Stryker
SYK
$127B
| $279K | ﹤0.01% |
3,430
-224,120
| -98% | -$17.8M |
|
771
Northwest Natural Holdings
NWN
$2.17B
| $276K | ﹤0.01% |
+6,260
| New | +$264K |
|
|
ETFC
772
DELISTED
E*Trade Financial Corporation
ETFC
| $276K | ﹤0.01% |
+12,000
| New | +$263K |
|
|
NBL
773
DELISTED
Noble Energy, Inc.
NBL
| $275K | ﹤0.01% |
3,870
-63,266
| -94% | -$4.19M |
|
774
Kulicke & Soffa
KLIC
$5.3B
| $272K | ﹤0.01% |
+21,600
| New | +$257K |
|
|
OA
775
DELISTED
Orbital ATK, Inc.
OA
| $269K | ﹤0.01% |
1,889
-259
| -12% | -$34.6K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2014 Portfolio in Review
As of Q1 2014, Jacobs Levy Equity Management held 1,150 positions worth $5.97B, down 10% from $6.66B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management withdrew a net $778M in Q1 2014, closing 276 positions and reducing 398 holdings. Its most notable exit was Allergan Inc, an estimated $52.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bristol-Myers Squibb worth $35.5M.
- Jacobs Levy Equity Management's largest Q1 2014 buy was Bristol-Myers Squibb: 683,110 shares worth $35.5M.
- Jacobs Levy Equity Management added most to Amazon in Q1 2014, an estimated $51.8M increase.
- Jacobs Levy Equity Management's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $40.3M.
- Jacobs Levy Equity Management fully exited Allergan Inc in Q1 2014, selling an estimated $52.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.97B portfolio in Q1 2014.
- Jacobs Levy Equity Management opened 217 new positions and closed 276 in Q1 2014.
- Jacobs Levy Equity Management's portfolio value fell 10% quarter-over-quarter to $5.97B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.